The QualityStocks Daily Tuesday, March 26th, 2019

Today's Top 3 Investment Newsletters

StockMarketWatch (HUNT) +416.02%

MarketClub Analysis (TAUG) +52.28%

CannabisNewsWire (REFG) +48.76%

The QualityStocks Daily Stock List

biOasis Technologies, Inc. (BIOAF)

Venture Beat, Proactive Investors, Stock News Now, MarketWatch, PennyStocks24, Tailwinds Research Group, Midas Letter, GuruFocus, Capital Cube, Zacks, OTC Markets Group, 4-Traders, Stockwatch, SmallCapFinancialWire, YCharts, The Street, and Uptick Newswire reported previously on biOasis Technologies, Inc. (BIOAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

biOasis Technologies, Inc. centers on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB). The delivery of therapeutics across the BBB represents the single greatest challenge in treating neurological disorders. The Company is developing and commercializing the xB3 platform, its proprietary blood-brain barrier delivery technology, to address unmet medical needs in the treatment of central nervous system (CNS) diseases and disorders. A biopharmaceutical business and OTCQB-listed, biOasis Technologies is headquartered in Richmond, British Columbia.

biOasis Technologies’ Transcend Platform is now available to be licensed by biotechnology and pharmaceutical companies for the advancement of their neurotherapeutic programs. The Transcend Platform has realized a considerable high level of success in dozens of studies at greater than 20 third-party institutions and pharmaceutical companies.

biOasis Technologies and BioAgilytix have a strategic collaboration to partner on the development and validation of bioanalytical methods to support and advance the xB3 TM-001 program, BiOasis’ lead candidate to treat HER2+ brain cancer, to investigational new drug (IND) submission and into the clinic. BioAgilytix is a leading provider of contract bioanalytical testing services with a specialization in large molecule bioanalysis.

biOasis Technologies has obtained full patent protection for its Transcend group of peptide carriers and linkers. The Transcend-peptide platform is currently referred to as the aforementioned xB3 platform. It is part of biOasis’ patented portfolio that is transforming therapeutic brain-drug delivery.

The Transcend Platform comprises a varied set of peptide carriers and linkers. These, together, provide transport solutions for a variety of CNS therapeutics. These include monoclonal antibodies, enzymes, small molecules, as well as different types of gene therapies. Transcend is founded on the naturally occurring human transport protein, melanotransferrin, also called MTf, CD228 and p97. MTf is found at low concentrations in the blood.

MTf is able to cross the BBB via a process called Receptor Mediated Transcytosis where MTf molecules attach to receptors on the cells of the BBB and is then pulled through the cells and into the brain. With the Company’s proprietary Transcend carrier, the MTf protein can be attached to therapeutics of different sizes and types.

Earlier in March, BiOasis Technologies announced that its Board Of Directors appointed Dr. Deborah A. Rathjen as President and Chief Executive Officer. Dr. Rathjen is a member of the Board and has served as Executive Chair since December 10, 2018.

Mr. David M. Wurzer, lead independent Director, said, “Deborah has significant experience in company building and financing, mergers and acquisitions, therapeutic product research and development, business development, licensing and commercialization. Her skills and track record, combined with her recent experience working closely with BiOasis management in her capacity as executive chair, put her in a strong position to assume leadership of company. I am delighted that Deborah has agreed to become our new CEO and look forward to continuing to work with her in this new role.”

biOasis Technologies, Inc. (BIOAF), closed Tuesday's trading session at $0.281567, down 5.07%, on 26,500 volume with 5 trades. The average volume for the last 3 months is 9,483 and the stock's 52-week low/high is $0.2096/$0.7435.

chart

Golden Predator Mining Corp. (NTGSF)

Penny Stock Hub, Mining Stock Valuator, Morningstar, Market Screener, OTC Markets, Barchart, The Street, Stockhouse, Gold Investment Letter, Junior Mining Network, 4-Traders, Investors Hangout, and Dividend Investor reported previously on Golden Predator Mining Corp. (NTGSF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Golden Predator Mining Corp. acquires and explores for mineral properties in the United States and Canada. It concentrates on its district scale, orogenic gold-in-quartz 3 Aces Project in the Yukon. The Company formerly went by the name Northern Tiger Resources, Inc. It changed its corporate name to Golden Predator Mining Corp. in April 2014. Golden Predator Mining is headquartered in Vancouver, British Columbia and lists on the OTC Markets’ OTCQX.

The 3 Aces Project hosts the two highest grade surface outcrops discovered to date in the Yukon. The 100 percent owned 3 Aces Project is 357 km2 (35,700 hectares). It is a high-grade gold project (Orogenic Gold Model).

The 3 Aces Project includes at least 6 mineralized areas. These are all located within and along favorable stratigraphic and structural zones that extend more than 35km along trend. Several mineralized veins have been discovered so far. Many have visible gold occurrences.

Golden Predator Mining also holds 100 percent of the advanced Brewery Creek Project in the Yukon. The Brewery Creek Mine is operated by the Company. The target at the Brewery Creek Mine is an intrusion related gold deposit. The Brewery Creek Mine is 55km east of Dawson in the northwestern region of the Yukon.

Golden Predator Mining announced this past January results of the 2018 drill program in the Central Core Area at the 3 Aces Project in southeast Yukon, which was completed to test for extensions of the high grade structures outcropping in the Hearts Zone. Seven HQ diamond drill holes consistently intercepted two parallel, closely spaced gold-bearing structures along 220m of strike and 500m down dip from the Hearts discovery outcrop. This was the deepest drilling so far on the project. The structures in the Hearts Zone continue to be open in all directions along strike and at depth.

In February, Golden Predator Mining reported that roughly 6 percent of the 9,800 metric tonne 2018 bulk sample, from the Spades Zone at the 3 Aces Project was successfully processed at the Company-owned test processing plant in Q4 2018.  Two concentrates were produced. Number 1 concentrate was poured into a 13,261.5 gram doré bar and shipped to Asahi Refinery in the Province of Ontario. There, it yielded 365 troy ounces of gold (86.28 percent gold) and 34 troy ounces silver (7.63 percent silver) providing a return of $471,386 USD ($623,823 CDN).

Furthermore, 658.1 kilograms (kg) of  Number 2 concentrate was recovered and remains in inventory at the plant for ensuing processing. Processing of the bulk sample material uses water and gravity only.

Moreover, in February, Golden Predator Mining announced plans for its exploration and drilling program in the Central Core Area of its 3 Aces Project in southeast Yukon. This program will center on following up the success of last year’s work that extended the high-grade Hearts Zone down dip and along strike towards the Clubs Zone. The expectation is that bulk sampling will enable the 2019 3 Aces exploration program to be self-funding.

Golden Predator Mining Corp. (NTGSF), closed Tuesday's trading session at $0.166, up 0.12%, on 56,325 volume with 12 trades. The average volume for the last 3 months is 48,473 and the stock's 52-week low/high is $0.1494/$0.4416.

chart

Cantabio Pharmaceuticals, Inc. (CTBO)

Profitable Trader Authority, HotStockProfits, Profitable Trading, Leeb’s Market Forecast, AwesomeStocks, OTCtipReporter, Investors Alley and PennyStockScholar reported previously on Cantabio Pharmaceuticals, Inc. (CTBO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Cantabio Pharmaceuticals, Inc. centers on bringing novel, first-in-class drug candidates into clinical trials and beyond. The Company does so through the discovery and development of ground-breaking pharmacological chaperone and protein delivery based therapeutics, focusing on protein systems implicated in neurodegenerative disorders. These include Alzheimer’s, Parkinson’s, and oxidative stress. At present, Cantabio is engaging in advanced pre-clinical trials of its therapeutic candidates and is focused on developing these towards clinical trials. A preclinical stage biotechnology company, Cantabio Pharmaceuticals is headquartered in Sunnyvale, California.

The Company is concentrating on commercializing novel therapies and the Intellectual Property (IP) produced from its research and development (R&D) activities for Parkinson’s disease (PD), Alzheimer’s disease (AD), and other related neurodegenerative diseases. Cantabio’s strategy combines a detailed therapeutic focus, target family biophysics, and drug discovery technology and expertise into an innovative drug discovery approach.

In addition, Cantabio is developing therapeutic proteins that can pass through the blood-brain barrier to supplement existing levels of proteins, which display loss of function during disease conditions. The Company has a new preclinical therapeutic program for Alzheimer’s disease that it is pursuing through its drug discovery partnership with NovAliX. The program is targeted at the development of small molecule chaperones that stabilize the Abeta peptide, the aggregation of which is considered to be a vital element in the onset and progression of Alzheimer’s disease.

This week, Cantabio Pharmaceuticals’ Dr. Gergely Toth, the Company’s Chief Executive Officer, presented the latest results from Cantabio's DJ-1 protein targeting small molecule pharmacological chaperone therapeutic program at the Milner Therapeutics Symposium on October 1, 2018. The Symposium is a key networking event for drug discovery professionals and Milner Therapeutics Institute alliance partners that includes companies such as AstraZeneca, GlaxoSmithKline, Shionogi, Pfizer and Johnson and Johnson.

DJ-1 is a novel and crucial target for the treatment of several conditions, as loss of DJ-1 protein function has been linked to the onset of an array of diseases including Parkinson’s disease, Alzheimer’s disease, stroke, amyotrophic lateral sclerosis, chronic obstructive pulmonary disease and type II diabetes. The DJ-1 protein is considered to be one of the chief therapeutic targets for Parkinson’s disease, as it is genetically linked to the onset of familial Parkinson’s.

Cantabio Pharmaceuticals, Inc. (CTBO), closed Tuesday's trading session at $0.0059, up 14.34%, on 380,800 volume with 11 trades. The average volume for the last 3 months is 211,028 and the stock's 52-week low/high is $0.0021/$0.10.

chart

Acacia Diversified Holdings, Inc. (ACCA)

Proactive Investors, MarketWatch, Zacks, Seeking Alpha, YCharts, Daily Marijuana Observer, Wallet Investor, PR Newswire, Corporate Information, 4-Traders, Otc.watch, Real Pennies, InvestorsHub, GlobeNewswire, Morningstar, Insider Financial, and Simply Wall St reported earlier on Acacia Diversified Holdings, Inc. (ACCA), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Acacia Diversified Holdings, Inc. is an emerging cannabis business headquartered in Clearwater, Florida. The Company’s wholly-owned subsidiaries are MariJ Pharmaceuticals, Inc. (MariJ) and Eufloria Medical of Tennessee, Inc. (Eufloria). Via these, Acacia concentrates on the growing and distribution of new and proprietary medicinal hemp products for patients, USDA certified organic mobile processing and handling solutions for its customers, and technology solutions for the expanding physician market. Acacia Diversified Holdings lists on the OTCQB.

Moreover, Dahlia's Botanicals is another part of the Acacia portfolio. A portion of sales from its U.S.D.A Certified Organic Hemp product goes to the Cannamoms organization.

MariJ Pharmaceuticals is the exclusive organic extraction company. MariJ’s focus is on the extraction and processing of very high quality, high-CBD/low-THC content medical grade cannabis oils from medical cannabis plants. MariJ specializes in organic strains of the plant. This sets itself apart from the general producers of non-organic products.

Additionally, MariJ Pharmaceuticals has the technical expertise and capability to process and formulate the oils and to use them in its compounding operations. Furthermore, it has its proprietary Geotraking Technology. This technology is totally compliant with the Health Insurance Portability and Accountability standard (HIPAA), using its “plant to patient” solution.

Acacia Diversified Holdings has a 14-acre farm with 32,000 square feet of indoor grow area in southern Tennessee. It acquired an option to purchase the farm, upon favorable terms, which option, Eufloria Medical of Tennessee intends to exercise. Acacia Diversified Holdings also acquired MEDAHUB Operations Group, Inc. and MEDAHUB, Inc. These are technology companies complete with a current compounding pharmacy license in the State of Florida.

Last month, Acacia Diversified Holdings announced its partnership with Tennessee State University (TSU) for potentially pioneering hemp research. Eufloria Medical of Tennessee will be manufacturing material for the university study. Eufloria is a vertically-integrated hemp operation, an innovative model of operations in Tennessee.

The research partnership aims to create a safe and chemical-free vehicle to obtain the health benefits of the whole-hemp plant into almost anything from food and beverages to topical creams. The TSU research could produce unique ways to obtain whole plant extract.

Acacia Diversified Holdings, Inc. (ACCA), closed Tuesday's trading session at $0.1299, up 10.37%, on 23,338 volume with 18 trades. The average volume for the last 3 months is 18,645 and the stock's 52-week low/high is $0.109/$0.85.

chart

Data Storage Corp. (DTST)

Buzz Stocks, Stock Guru, Planet Penny Stocks, PennyStocks24, Priceless Penny Stocks, Stock Twiter, SecretStockPromo, Stock Onion, EpicVIP Group, Penny Picks, Penny Stock Prophet, Bull Trends, Information Solutions Group, Stock Mister, Real Pennies, Epic Stock Picks, TopPennyStockMovers, Wolf of Penny Stocks, Actual Gains, Penny Stock Rumors, Penny Pick Finders, Rocking Penny Stocks, Penny Dreamers, and Alpha Penny Stock reported beforehand on Data Storage Corp. (DTST), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Data Storage Corp. provides cloud-based technology solutions. The Company provides hardware, software-as-a-service (SaaS), managed IT (Information Technology) services, installation, and maintenance, centered on compliance, message archiving, analytics, disaster recovery, and business continuity. Message Logic is a business unit of the Company. OTCQB-listed, Data Storage has its corporate office in Melville, New York.

A Cloud Services Provider, the Company has acquired ABC Services and ABC Services II (a 25-year provider of IBM equipment, IAAS, managed and professional services) including the remaining 50 percent ownership of Secure Infrastructure and Services. With this acquisition, Data Storage expands its current solutions.

Data Storage provides its solutions and services through taking advantage of top technologies. These include virtualization, cloud computing, and cloud storage. The Company created Nexxis, Inc. This subsidiary concentrates on the development of next-generation voice and data services intended to help companies speed up their communications, increase revenue, and reduce costs.

Data Storage’s solutions include offsite data protection and recovery services, High Availability (HA) replication services, email compliance solutions for e-discovery, continuous data protection, data de-duplication, virtualized system recovery, and telecommunications recovery services. The Company’s Message Logic business unit delivers regulatory compliant email archiving and analytics to enterprises around the world.

Message Logic’s MLArchiver provides a solution uniting archiving, records management, eDiscovery, and analytics to deliver a new level of advanced capabilities. Additionally, Data Storage’s Secure Infrastructure & Services focuses on providing infrastructure as a service (IAAS). It specializes in power systems, iseries and AS400 users.

At the end of January, Data Storage announced that it received a $3.5 million contract to provide state-of-the-art data protection services at its newest data center located in North Carolina. By way of its partnership programs, Data Storage was chosen to provide its ezMirror real-time replication program as the ideal solution for the client’s significant data protection requirements. ezMirror offers automated real-time replication that keeps data in sync with minimum management and near-zero data loss, permitting fast recovery in the event of a disaster. ezMirror will provide the apparel retailer state-of-the-art data protection requirements for their mission-critical IBM i and AIX applications.

Data Storage Corp. (DTST), closed Tuesday's trading session at $0.1486, up 3.63%, on 18,617 volume with 17 trades. The average volume for the last 3 months is 10,375 and the stock's 52-week low/high is $0.0806/$0.6949.

chart

Khiron Life Sciences Corp. (KHRNF)

Capital Network, Wallmine, OTC Markets, Wallet Investor, Investing News, Barchart, Morningstar, InvestorsHub, Pot Network, Penny Stock Hub, Stockwatch, Stockhouse, Midas Letter, Investors Hangout, TradingView, Proactive Investors, MarketWatch, Market Screener, and GuruFocus reported beforehand on Khiron Life Sciences Corp. (KHRNF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Khiron Life Sciences Corp. is a Canadian integrated medical cannabis business. The Company has its core operations in Colombia. Khiron is fully licensed in Colombia for the cultivation, production, domestic distribution, and international export of tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. Khiron Life Sciences is headquartered in Toronto, Ontario and it also has an office in Bogota, Colombia. The Company’s shares trade on the OTCQB.

Khiron Life Sciences combines worldwide scientific expertise, agricultural advantages, branded product market entrance experience and education to grow prescription and brand loyalty to address priority medical conditions. These conditions include chronic pain, epilepsy, depression and anxiety in the Latin American market. The Company is establishing research partnerships with some of Colombia’s top medical associations – the Colombian Association of Neurology being one of them.  

Khiron also has the advice of the best laboratories from Israel and Canada in genetics and, production and clinical data of medical cannabis. Concerning the cultivation process and product development, it has developed a temperature, humidity, and air circulation control system, which ensures that the plant grows in a controlled natural environment. Its cultivation is hydroponic.

Khiron Life Sciences announced this past January that it entered into a binding letter agreement, dated January 24, 2019, to acquire 100 percent of NettaGrowth International, Inc. (NettaGro), an arm's length party that will own, at the time of completion of the transaction, all the outstanding shares of Dormul S.A. (d/b/a Cannapur). Dormul has obtained the first license to produce medical cannabis with THC for commercialization in Uruguay.

Dixie Brands, Inc. and Khiron Life Sciences signed a definitive agreement relating to the joint venture (JV) the companies announced on January 30, 2019. With the execution of this Agreement, a new company named Dixie Khiron JV Corp. (Dixie-Khiron) was established, 50 percent owned by each of Dixie Brands and Khiron Life Sciences. Dixie Brands is one of the cannabis industry's foremost consumer packaged goods (CPG) companies.

Dixie-Khiron will leverage the complementary strengths of both companies to manufacture and distribute cannabis-infused products to the Latin American market. With this Agreement, Dixie Brands will also manufacture and distribute Khiron's Kuida® brand of cannabidiol (CBD)-based cosmeceuticals in the U.S. The expectation is that Kuida will be widely distributed. It is anticipated to have particular appeal to the growing U.S. Hispanic population, estimated at close to 60 million.

Khiron Life Sciences Corp. (KHRNF), closed Tuesday's trading session at $2.93, up 2.67%, on 407,407 volume with 450 trades. The average volume for the last 3 months is 458,620 and the stock's 52-week low/high is $0.6637/$3.279.

chart

Monarch Gold Corporation (MRQRF)

InvestorsHub, The National Investor, Northern Vertex, Canadian Insider, Barchart, Junior Mining Network, The Street, 4-Traders, Mining & Energy, MarketWatch, Northern Miner, Morningstar, PR Newswire, GuruFocus, Private Capital News Wire, Stockhouse, YCharts, 24hgold, and Market Screener reported earlier on Monarch Gold Corporation (MRQRF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Monarch Gold Corporation is a developing gold producer listed on the OTC Markets. Its emphasis is on pursuing growth via its large portfolio of high-quality projects in the Abitibi mining camp in Quebec. The Company previously went by the name Monarques Resources, Inc. and Monarques Gold Corporation. Monarch Gold has its head office in Montreal, Quebec.

Monarch Gold owns almost 300 km² of gold properties. These include the Beaufor Mine, the Croinor Gold, Wasamac, McKenzie Break and Swanson advanced projects. Furthermore, the Company owns the Camflo and Beacon mills, and six promising exploration projects. In addition, Monarch offers custom milling services out of its 1,600 tonne-per-day Camflo mill.

Annual production at the Beaufor Mine is +20K ounces. The Beaufor Mine has strong drilling results. This includes 61.48 g/t Au over 3.9 m. There is excellent potential to increase the resource at Beaufor.

In late 2018, Monarch Gold reported positive results from the Feasibility Study (FS) prepared by BBA, Inc. for the Wasamac Gold project, situated 15 km west of Rouyn-Noranda, in Abitibi, Quebec. The results of the FS show that Wasamac is an economically viable project expected to be a low-cost producing mine. Also, the FS provides the basis for making a production decision. It also serves to totally support the permitting and financing processes.

Last week, Monarch Gold reported the third and last set of assay results from the 2018 diamond drilling program at its wholly-owned McKenzie Break gold project 25 kilometers north of Val-d'Or, close to its Camflo and Beacon mills. The program commenced in September 2018. It ended in December of 2018 with a total of 13,945 meters drilled in 61 holes.

The purpose of the program was to explore below the known lenses and on the periphery of the multi-vein Green and Orange zones. Assays were received for the last 20 holes totaling 5,052 meters of core.

Mr. Jean-Marc Lacoste, Monarch Gold’s President and Chief Executive Officer, said, "With the solid high-grade results obtained from our 2018 drilling program, we have upgraded the status of McKenzie Break as one of our prime advanced exploration projects. The program delivered beyond our expectations, enabling us to establish that the deposit remains open to the west, east, north and at depth and continues to hold excellent high-grade gold potential.”

Monarch Gold Corporation (MRQRF), closed Tuesday's trading session at $0.219, up 4.29%, on 4,000 volume with 2 trades. The average volume for the last 3 months is 37,937 and the stock's 52-week low/high is $0.1084/$0.2906.

chart

Silver Bull Resources, Inc. (SVBL)

Awesome Penny Stocks, Stock Twits, The Street, Simply Wall St, Street Insider, Zacks, Silicon Investor, Proactive Investors, MarketWatch, InvestorsHub, Streetwise Reports, Wallet Investor, Investors Hangout, Wall Street Resources, GuruFocus, Stockhouse, Barchart, TopPennyStockMovers, RedChip, Streetwise Reports, Seeking Alpha, Stock Stars, and Stockopedia reported earlier on Silver Bull Resources, Inc. (SVBL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Silver Bull Resources, Inc. is a mineral exploration company based in Vancouver, British Columbia. Its flagship project is called "Sierra Mojada". This Project is 150 kilometers north of the city of Torreon in Coahuila, Mexico. The Project is highly prospective for silver and zinc. An exploration stage enterprise, Silver Bull Resources lists on the OTC Markets Group’s OTCQB.

The Sierra Mojada Project is 100 percent owned and operated by the Company. The Project is part of a massive land package comprising 40 mining concessions totaling 21,167 hectares (52,305 acres), situated in an historical high-grade silver, lead, zinc mining district discovered in 1879. Sierra Mojada is an open pittable oxide deposit.

The Sierra Mojada Project has an NI (National Instrument) 43-101 compliant measured and indicated Global resource of 58.7 million tonnes grading at 3.6 percent zinc and 50 g/t silver for 4.670 billion pounds of zinc and 90.8 million ounces of silver. Sierra Mojada has high-quality infrastructure that includes a railway to the site; a paved road; grid power, and five company-owned water wells.

The primary mineralization zone found at Sierra Mojada extends greater than six kilometers in an East-West direction along the base of the Sierra Mojada Range parallel with the Sierra Mojada fault. This area has not been mined with modern mining technology and processes.

Silver Bull Resources earlier acquired a new mineral license in the Palomas Negros area. The prospect lies 9 kilometers to the northwest of the main deposit at Sierra Mojada. The mineral license obtained is a 68 hectare historical mineral license. It had been cancelled for many years by the Mexican mining authorities, and therefore had no official owner. However, it had not been released for staking until recently.

In October 2018, Silver Bull Resources announced an updated NI 43-101 resource on the significant oxide mineralization already defined at Sierra Mojada. Highlights of the resource update include an open pittable, measured and indicated “High Grade Zinc Zone” of 13.5 million tonnes at an average grade of 11.2% Zinc at a 6% cutoff for 3.336 billion pounds of zinc.

Highlights also include an open pittable, measured and indicated “High Grade Silver zone” of 15.2 million tonnes at an average grade of 114.9 g/t at a 50g/t cutoff for 56.3 million ounces of silver. In addition, highlights include Total Measured & Indicated Global Resource of 70.4 million tonnes at 38.6 g/t Ag and 3.4% Zn, which contain 5.354 billion pounds Zn and 87.4 million ounces Ag.

Last month, Silver Bull Resources provided an update on the Sierra Mojada project. The Company announced the forthcoming start of an 8,000 meter surface drill program to target a series of the sulphide extension at depth of the main deposit already defined at Sierra Mojada and a series of never before tested targets within the wider area. Regarding the 2019 Exploration Drill Program, Silver Bull signed a drill contract with Major Drilling De Mexico S.A de C.V to conduct the 8,000 meter drill program initially targeting 4 historic mining areas within the Sierra Mojada property.

Silver Bull Resources, Inc. (SVBL), closed Tuesday's trading session at $0.1001, down 3.75%, on 98,867 volume with 16 trades. The average volume for the last 3 months is 176,460 and the stock's 52-week low/high is $0.085/$0.20.

chart

Dyadic International, Inc. (DYAI)

Stockflare, MicroCapDaily, YCharts, Journal Transcript, Capital Cube, Stockhouse, Zacks, Street Insider, Equity Clock, GuruFocus, Proactive Investors, Investors Hub, MarketWatch, Morningstar, Corporate Connect, Market Screener, and Stockopedia reported on Dyadic International, Inc. (DYAI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Dyadic International, Inc. is a global biotechnology company listed on the OTCQX. Its emphasis is on further improving and applying its proprietary C1 gene expression platform to expedite the development and lessen the cost of biologic vaccines and drugs at flexible commercial scales. Dyadic International has its corporate headquarters in Jupiter, Florida. The Company has a foreign subsidiary, Dyadic Nederland, BV, which maintains a small satellite office in Wageningen, the Netherlands.

Dyadic International has developed a method for producing commercial quantities of enzymes and other proteins needed for the production of industrial enzymes. The Company has successfully licensed this technology to third parties including Abengoa Bioenergy, BASF, Codexis as well as others.

The foundation of the technology is on the Myceliophthora thermophila fungus, which Dyadic named C1. The C1 technology is a strong and versatile fungal expression system for gene discovery, development, expression and production of enzymes and other proteins.

Dyadic International’s C1 Expression System is an optimized and industrially proven system. It turns genes into a wide range of valuable products. The C1 Technology Platform helps to overcome some of the inadequacies of existing expression technologies used for gene discovery, product development and commercialization. Dyadic International is seeking research collaborations, government funding, partners, and sub-licensees in which to apply the C1 platform in the vaccine, antibody, biosimilar and biobetters industries.

In September, Dyadic International announced that it entered into a fully funded proof of concept research collaboration with Sanofi-Aventis Deutschland GmbH to explore the potential of its C1 technology to produce multiple kinds of biologic vaccines and drugs of interest for human health indications. Sanofi-Aventis Deutschland GmbH is a company of the Sanofi group, one of the world’s top tier biopharmaceutical enterprises.

With this agreement, Sanofi-Aventis will fund the collaborative research that will use the proprietary and patented C1 Gene Expression Platform Technology to express multiple genes for vaccine and drug applications. The expectation is that the research will be completed in the second half of 2019.

Dyadic International, Inc. (DYAI), closed Tuesday's trading session at $3.23, up 0.78%, on 103,949 volume with 117 trades. The average volume for the last 3 months is 44,378 and the stock's 52-week low/high is $1.39/$3.25.

chart

Maple Gold Mines Ltd. (MGMLF)

Jet Life Penny Stocks, Dividend Investor, Wallet Investor, InvestorsHub, GuruFocus, MarketWatch, Wall Street Nation, OTC Markets, Stockwatch, Stockhouse, 4-Traders, Junior Mining Network, TradingView, Barchart, and InvestorsHangout reported earlier on Maple Gold Mines Ltd. (MGMLF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Maple Gold Mines Ltd. is an exploration company focused on advancing a district-scale gold project in one of the world’s premier mining jurisdictions. The Company’s 370 km2 Douay Gold Project is within the prolific Abitibi Greenstone Belt in northern Quebec. The Douay Gold Project has excellent infrastructure with large operating mines within 150 kms. There is significant resource expansion and exploration upside at the Douay Gold Project.

OTCQB-listed, Maple Gold Mines has its management office in Toronto, Ontario. The Company formerly went by the name Aurvista Gold Corporation. It changed its name to Maple Gold Mines Ltd. in November 2017.

The Douay Project has an established gold resource that remains open in numerous directions. Maple Gold is focusing on expanding the known resource areas and testing new discovery targets within its 55 km of strike along the Casa Berardi Deformation Zone.

The updated resource estimate (NI 43-101 Technical Report - March 2018) successfully converted a major proportion of Inferred to the Indicated Resource category, at Douay West and Porphyry Zones. Resources at Douay now stand at 2.76 million ounces Inferred plus 0.48 million ounces Indicated.

This past July, Maple Gold Mines reported the final drill results from the NW Gap Area - the area between the NW, Douay West and Porphyry Zones that includes the new Nika Zones. There were a select number of historical drill-holes drilled in the NW Gap Area from 2011 to 2017 inclusive by Aurvista Gold (now Maple Gold Mines). However, because of the limited drill density, the area represented a high-priority target for new discoveries and potential extensions of existing zones outside the presently established conceptual pits (Micon 2018). Within this area, 12 holes were drilled this year, with the majority spaced from 100 up to 300 meters from the nearest pre-existing drill collar.

Mr. Fred Speidel, Maple Gold Mines’ Vice President Exploration,  stated: "Assays for the NW Gap Area, including the promising new Nika Zones, are now complete. These additional results demonstrate that gold mineralization in the Nika Zones, part of which is well above deposit average grade, widens significantly towards the west and locally remains open up-dip and down-dip."

In September, will all assays being received, Maple Gold Mines provided a highlights summary of the 2018 drilling campaign. The 2018 winter drilling campaign included 21,122 meters of diamond drilling from 52 holes and 1,471.3 meters from 57 short top-of-bedrock Reverse Circulation (RC) holes for a total of 22,593 meters.

The assay results from drilling in the central part of the Porphyry Zone (including DO-18-216) support Maple Gold’s concept of manifold higher-grade zones or shoots within the Porphyry Zone. The assay results also demonstrate the continuity of this style of mineralization in the central part of the Porphyry Zone and open the possibility of increasing grades at depth.

Highlighted results from the east-central part of the Porphyry Zone (DO-18-247, DO-18-254 and DO-18-244) targeted an area with lower drill density and intersected appreciably higher grades than neighboring holes. This indicates that grade may increase at depth in this area.

Furthermore, drilling in the western half of the Porphyry Zone (west of DO-18-216) confirmed the presence of a broad (90- to 130-meter true width) halo of gold mineralization, extending several hundred meters along strike and primarily hosted in syenites (DO-18-229, DO-18-230, DO-18-234).

Maple Gold Mines Ltd. (MGMLF), closed Tuesday's trading session at $0.06575, up 4.20%, on 179,800 volume with 10 trades. The average volume for the last 3 months is 94,616 and the stock's 52-week low/high is $0.061992/$0.229.

chart

Medicine Man Technologies, Inc. (MDCL)

Stockwatch, Insider Financial, Stockopedia, Marketbeat, Stockhouse, Insider Tracking, Simply Wall St, Daily Marijuana Observer, The Street, CFN Media Group, and MarketWatch reported on Medicine Man Technologies, Inc. (MDCL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Medicine Man Technologies, Inc. represents and licenses the cultivation and dispensary Intellectual Property (IP) of Medicine Man - a well-respected Tier III operator in Colorado. Medicine Man Technologies provides cultivation consulting services for cannabis growing technologies and methodologies. The Company is one of the nation’s top cannabis brand development and consulting enterprises. Medicine Man Technologies has its head office in Denver, Colorado.

Medicine Man is concentrating on working with clients to use its experience, technology, and training to help secure licenses in states with newly emerging regulations. Furthermore, the Company is focusing on cultivation practices by way of its deployment of Cultivation MAX and eliminating the liability of single grower dependence.

Medicine Man Technologies works closely with industry-leading extraction partners. These partners provide the necessary licensing service support and formulations to help customers with their planned deployment of a successful processing facility.

Medicine Man’s risk-averse cannabis cultivation technology delivers consistent, high quality, high yield production within a clean-room style environment. The Company’s state-of-the art dispensary model ensures patients and consumers have safe and secure access to a variety of medical and/or recreational cannabis products.

Moreover, Medicine Man Technologies is continuing the expansion of its Brands Warehouse concept. In addition, it engages in retail operations of cannabis products. The Company also provides general business and referral management for other related service providers for its customers. Medicine Man cultivates and sells through its parent company Medicine Man Denver, the largest cultivation/retail facility in Colorado.

Medicine Man Technologies and Solis Tek, Inc. have a cooperative agreement. Solis Tek will become Medicine Man Technologies' recommended supplier of High Intensity Discharge (HID) lighting technologies for its present and prospective consulting and sales relationships. Medicine Man has completed and totally integrated three acquisitions. These are Pono Publications, Success Nutrients, and the Denver Consulting Group.

Recently, Medicine Man Technologies announced it completed the acquisition of the Big Tomato retail supplier business effective September 17, 2018. The Big Tomato retail business has been open since 2001. The anticipation is that it will produce about $2.5M in revenues in 2018. The business carries a broad assortment of grow related products. In addition, it will be acting as another distribution hub for Medicine Man’s Success Nutrients product line.

Mr. Jeremy Stout, Big Tomato’s Managing Partner, stated, “My partners and I are very excited about this new opportunity to align ourselves with Medicine Man Technologies, Inc. We all believe we can provide the Company’s clients with competitive pricing for their nutrient products that will continue to meet their respective specifications through our established relationships in the cannabis industry.”

Medicine Man Technologies, Inc. (MDCL), closed Tuesday's trading session at $2.08, up 2.97%, on 146,653 volume with 168 trades. The average volume for the last 3 months is 108,098 and the stock's 52-week low/high is $1.059/$2.53.

chart

Digerati Technologies, Inc. (DTGI)

Emerging Growth, Real Investment Advice, Wallet Investor, OTCPicks, AllPennyStocks, MicrocapVoice, Equities, Marketwired, SmallCapVoice and Stockopedia reported on Digerati Technologies, Inc. (DTGI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Digerati Technologies, Inc. is a diversified holding company based in San Antonio, Texas. It has subsidiary operations in the cloud communications industry. The Company, through its wholly-owned subsidiary, Shift8 Technologies, Inc., provides Internet-based telephony products and services by way of its cloud telephony application platform and session-based communication network. Digerati Technologies lists on the OTCQB.

In essence, Digerati Technologies is an established and award-winning provider of cloud communication services. It serves traditional carriers, telephony resellers, and other VoIP (Voice over Internet Protocol) carriers in the U.S. and internationally. The Company provides VoIP communication services to telecommunications enterprises.

The Company’s Shift8 Networks subsidiary is an enterprise hosted PBX and cloud-based Unified Communications service provider. Shift8 Networks provides voice, video, and mobile communications to thousands of businesses through its Channel Alliance program. Shift8 integrates hosted VoIP with cloud-based messaging and desktop applications. Shift8's VAR program targets PBX Vendors, Information Technology (IT) Services firms, Managed Service Providers, and Systems Integrators that lack a cloud telephony infrastructure, but have an embedded customer base that necessitates Internet-based telephony services.

Additionally, Digerati Technologies provides Internet-based services. These include fully hosted IP/PBX services, IP trunking; call center applications, prepaid services, and interactive voice response auto attendant. Also, services include call recording, simultaneous calling, voicemail to email conversion, and manifold customized IP/PBX features in a hosted or cloud environment for specialized applications.

In 2017, Digerati Technologies completed the acquisition of Synergy Telecom, Inc. Digerati’s Shift8 Networks combined Synergy Telecom with its Texas-based business and operations. Synergy Telecom is a top provider of cloud communication services in Texas.

Digerati also completed the acquisition of T3 Communications, Inc. in 2018. It stated that this acquisition positions Digerati Technologies for hyper-growth in two of the fastest growing sectors of the telecommunications industry, UCaaS (Unified Communications as a Service) and SD-WAN (Software-Defined Wide-Area Network). T3 Communications is a leading provider of cloud communications and broadband solutions in Southwest Florida.

Last week, Digerati Technologies announced that it launched a mobile ‘business continuity’ solution in partnership with Otarris, a division of Kajeet, Inc., for addressing the growing demand for disaster recovery networks in the enterprise marketplace. The Company is addressing the growing need for its customers to deploy a redundant and varied bandwidth solution for ‘business continuity’ during primary network outages. These include those caused by natural or human-induced disasters.

Digerati Technologies will offer its wireless solution via its operating subsidiaries Synergy Telecom and T3 Communications. Its wireless solution will be marketed mainly as a back-up solution. However, Digerati will sell its wireless service as a primary network to customers with limited access to a reliable broadband network.

Digerati Technologies, Inc. (DTGI), closed Tuesday's trading session at $0.22, up 4.27%, on 22,800 volume with 3 trades. The average volume for the last 3 months is 52,431 and the stock's 52-week low/high is $0.0701/$0.569.

chart

AmpliTech Group, Inc. (AMPG)

Information Solutions Group, Pumps and Dumps, HoleinOneStocks, HotStockProfits, Trading Wall St, Penny Stock Gainers, RockingPennyStocks, BestStocksDaily, Wallstreetbuzz, fusionspicks, Jet-Life Penny Stocks, OTCMagic, Ascending Stocks, AllPennyStocks, SmallCapVoice, PennyStocks24, and Fortune Penny Stocks reported on AmpliTech Group, Inc. (AMPG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AmpliTech Group, Inc. designs, develops, and manufactures custom and standard state-of-the-art RF Low Noise Amplifiers (LNA) and Power Amplifiers (PA). These are for the domestic and international, SATCOM, Space, and Military markets. Additionally, the Company provides consulting services to help with any microwave components or systems design problems. AmpliTech Group has its head office in Bohemia, New York. The Company lists on the OTCQB.

AmpliTech Group’s designs encompass the frequency spectrum from 50 kHz to 40 GHz - eventually providing designs up to 100 GHz. The Company can provide complex, custom solutions for almost any custom requirements presented to it. It can provide contract assembly of customers' own designs.

AmpliTech uses the most contemporary CAD microwave simulation technology to design and develop from concept to final manufacture of a deliverable product with premier accuracy. The Company expects to release new products targeted at the wireless and satellite markets, which will provide advanced technology and performance.

AmpliTech Group provides its customers with consulting services for their system development. Moreover, the Company provides technical assistance in integration and packaging technologies and microwave sub-systems and amplifier related sub-assemblies.

In 2017, AmpliTech Group announced that it entered into a Joint Venture (JV) Agreement with Trusted Networks, Inc. (TN). The focus of the JV is to develop an affordable mixed signal chipset, which can be used at server/router level and in mobile PDA applications to provide secure and encrypted communication with the aim of preventing hacking and cyber-attacks. TN is a New York, New York based private company with facilities in Colorado Springs and Nashua, New Hampshire.

In September, AmpliTech Group announced that it reached 2 million dollars in sales backlog as of mid-September, which is a record milestone. Since profit margins are up by an average of almost 20 percent over last year based on basic job-costing analysis, the expectation is that annual financial reports will show increases in revenue.

Louisa Sanfratello, Chief Financial Officer, said, “The $500,000 in bookings since our last press release on August 3rd is better than anticipated. Combined with positive sales projections for the final quarter, this bodes very well for the overall fiscal year.”

AmpliTech Group, Inc. (AMPG), closed Tuesday's trading session at $0.043, up 1.18%, on 135,000 volume with 3 trades. The average volume for the last 3 months is 38,663 and the stock's 52-week low/high is $0.0265/$0.0748.

chart

IDM Mining Ltd. (IDMMF)

Stockhouse, InvestorsHub, and MarketWatch reported on IDM Mining Ltd. (IDMMF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

IDM Mining Ltd. is a mineral exploration and development company listed on the OTC Markets Group’s OTCQB. The Company focuses on low capital expenditure, high-grade precious metal asset development. Its present exploration and development activities center on precious metals in British Columbia (B.C.). IDM’s primary emphasis is on the high-grade, underground Red Mountain Gold Project. IDM Mining is headquartered in Vancouver, British Columbia.

The Red Mountain Gold Project is 15 kilometers east of Stewart, B.C. It consists of17,125 hectares. IDM Mining is advancing through the B.C. and Canadian environmental assessment processes with complete, thorough, and continuing consultation with Nisga'a Nation.

Red Mountain has premier exploration potential for more discoveries along a 12-kilometer trend of numerous prospects and favorable geology. IDM Mining is advancing a Feasibility Study (FS) for a high-grade, underground gold mine. It envisions primarily bulk underground mining methods and the production of gold doré on site.

Red Mountain hosts a well-drilled, high-grade resource, accessed by a production-sized underground decline. The deposit (at an average potential mining width of 16 meters) is amenable to low-cost bulk mining techniques such as longhole stoping. In July, IDM Mining announced additional surface sampling results from trenching at the Money Rock zone at the Lost Valley target, within the 100 percent-owned Red Mountain Gold Project situated in the Golden Triangle of northwestern British Columbia, near the town of Stewart, BC. Assay results were received for an additional 51 panel samples, collected on one-meter intervals from the Money Rock structure at Lost Valley. The samples average 9.81 g/t Au and 101.40 g/t Ag over 51 meters of strike, including 2.0 meters averaging 13.41 g/t Au and 1,531 g/t Ag. Samples range from trace gold and silver to 49.43 g/t Au and 2,617 g/t Ag.

In August, the Company announced that the NI 43-101 Technical Report titled "Mineral Resource Update for the Red Mountain Gold Project, Northwestern BC, Canada " was filed on SEDAR. The Independent Technical Report was prepared by Dr. Gilles Arseneau , P.Geo. and Andrew Hamilton , P.Geo.

Recently, IDM Mining announced that the British Columbia Environmental Assessment Office (EAO) completed the Application Review phase for the proposed Red Mountain Gold Project. The EAO referred IDM’s Application for an Environmental Assessment Certificate (EAC) to the Minister of Environment and Climate Change Strategy and the Minister of Energy, Mines and Petroleum Resources for a decision.

IDM Mining Ltd. (IDMMF), closed Tuesday's trading session at $0.0485, up 20.95%, on 87,341 volume with 4 trades. The average volume for the last 3 months is 48,063 and the stock's 52-week low/high is $0.029/$0.066.

chart

The QualityStocks Company Corner

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products (CSE: PLUS) (OTCQB: PLPRF) this morning reported its unaudited revenue estimate for the fiscal period ended December 31, 2018 of $8.4 million, representing an enormous growth of 684% from fiscal 2017 revenues of $1.1 million. Additionally, the company reported revenue estimates of $3.4 million for the fourth quarter of 2018, an increase of about 32% over the third quarter of 2018. To view the full press release, visit: http://nnw.fm/gsDn2.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $4.1939, up 0.84%, on 102,167 volume with 288 trades. The average volume for the last 3 months is 77,798 and the stock's 52-week low/high is $2.81/$6.008.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE:TCAN) (FSE: TH8) ("TransCanna" or "the Company") provides the following update further to its press release dated March 25, 2019. The Company retained the services of GreenGrowth CPA , an independent third-party chartered professional accounting firm (the "Firm") 's located in Los Angeles, CA specializing in legalized cannabis.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $4.31, up 11.95%, on 506,795 volume with 366 trades. The stock's 52-week low/high is $0.769/$4.35.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a report by CannabisNewsWire examining how analysts at Brightfield Group see CBD (cannabidiol) gobbling up a sizeable chunk of a projected $100 billion nutraceuticals 2022 U.S. market. Also today, the company was highlighted in a publication from Pot Stock News looking at the share price performance subsequent to signing an equipment purchase agreement with EnWave Corporation (TSXV:ENW).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.67, up 0.55%, on 937,154 volume with 1,233 trades. The average volume for the last 3 months is 1,385,190 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was highlighted today in a report by CannabisNewsWire examining how analysts at Brightfield Group see CBD (cannabidiol) gobbling up a sizeable chunk of a projected $100 billion nutraceuticals 2022 U.S. market.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $3.55, up 0.32%, on 131,901 volume with 196 trades. The average volume for the last 3 months is 212,284 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) today announced the addition of the Pure and Pure Plus tinctures to its CBD+ Wellness line of products. Pure and Pure Plus tinctures, formulated with hemp-derived CBD, milk thistle and hemp seed oil, are designed to provide relief from inflammation and support healthy liver and heart function. To view the full press release, visit: http://cnw.fm/o6vkG. Also today, CannabisNewsWire released a report highlighting the company which examines the recent news that analysts at Brightfield Group see CBD (cannabidiol) gobbling up a sizeable chunk of a projected $100 billion nutraceuticals 2022 U.S. market.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.53, up 0.95%, on 31,103 volume with 24 trades. The average volume for the last 3 months is 14,104 and the stock's 52-week low/high is $0.009/$1.139.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) envisions a year of growth and expansion through its focus on cannabis beverages made using a revolutionary process featuring water-soluble ingredients. NOTE TO INVESTORS: The latest news and updates relating to SRUTF are available in the company’s newsroom at http://nnw.fm/SRUTF.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.394, up 23.82%, on 1,243,906 volume with 432 trades. The average volume for the last 3 months is 256,500 and the stock's 52-week low/high is $0.189/$1.875.

Recent News

chart

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

BriaCell Therapeutics (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company developing targeted, safe treatments for cancer, this morning announced that it has closed the first tranche of a non-brokered private placement of up to 20,000,000 of its common shares, each at a price of C$0.10, for gross proceeds of up to approximately C$2,000,000. To view the full press release, visit: http://nnw.fm/DSoc2 and http://nnw.fm/fwO0K.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.08572, up 3.15%, on 34,280 volume with 10 trades. The average volume for the last 3 months is 22,349 and the stock's 52-week low/high is $0.0495/$0.135.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (OTCQB: SGMD) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. To view the full publication, titled, “Hydroponic Supplies Play Key Role in Hemp Market Growth,” please visit: http://cnw.fm/G90Xe.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.0547, up 0.68%, on 925,156 volume with 71 trades. The average volume for the last 3 months is 1,368,006 and the stock's 52-week low/high is $0.0425/$0.259.

Recent News

chart

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)

The QualityStocks Daily Newsletter would like to spotlight Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN).

Canadian iron ore exploration and development company Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) continues to make solid progress advancing its 100 percent owned Shymanivske iron ore deposit located in Kryvyi Rih, Ukraine. Black Iron recently announced positive momentum in its search for a parcel of land suitable for the company’s processing plant, tailings and waste rock associated with the Shymanivske project (http://nnw.fm/xA5Gl).

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske Iron Ore Project, located in Krivyi Rih, Ukraine. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost.

The Market

Iron ore concentrates are one of the essential raw materials used by the steel industry to either make sinter or highly valued pellets. Black Iron’s concentrate can be used in either application and is an ideal source to make pellets since it does not need to be ground finer and contains very few impurities. According to the CRU Group, an internationally recognized top global business intelligence provider and consultancy specializing in commodities, there is a growing global shortage of pellet feed resulting in a supply/demand gap of 133Mt against the current base of approximately 400Mt consumed by 2035. According to a recent report issued by Zion Market Research, the global iron ore pellets market was valued at around US$25.22 billion in 2017 and is expected to reach US$50.12 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1 percent between 2018 and 2024 (http://nnw.fm/2vaDR).

Countries around the world, most notably China (http://nnw.fm/Je8gs), have instituted regulatory changes to curb polluting emissions from steel mills through numerous methods, including encouraging a shift to higher grade iron feed products such as pellets as less coal needs to be burnt per ton of steel produced.

Shymanivske Project

Black Iron’s Shymanivske’s project, which is expected to produce ultra-high-grade 68 percent iron content pellet feed iron concentrate, is generating significant interest from steel mills and global commodity trading houses. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added product to customers since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced.

The project’s proximity to rail lines (1 mile), electrical power (20 miles), sea ports (140 to 260 miles) and a skilled workforce (6 miles) significantly reduces the up-front construction costs and allows for the mine to be built in a phased approach. The Shymanivske project has been ranked by the CRU Group in the lowest position of the business cost curve for pellet feed projects currently under development and as the second lowest in capital intensity (construction capital divided by annual production) within CRU Group’s extensive database (http://nnw.fm/3MXsT). This low-cost position makes the project economics very robust to any shocks in iron ore price while providing a very high return at current and forecast prices.

Black Iron continues to advance its project on several fronts including construction funding and off-take agreements (http://nnw.fm/tQ4g2). Discussions with Ukraine’s Ministry of Defense to transfer a parcel of land required by the company for location of its processing plant, waste rock and tailings are nearing finalization, as are discussions with the Kryviy Rih City Council to lease a portion of the surface rights currently under that body’s control. The recent engagement of Ivan Markovich as Black Iron’s Vice President of Government and Community Relations will assist the company in these endeavors given his extensive network of relationships with senior Ukraine government officials.

The Shymanivske project holds a mining allotment permit for a large iron ore deposit with a NI 43-101 compliant resource estimated to contain 646 Mt (million tons) Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6% total iron and 18.8% magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1% total iron and 17.9% magnetic iron, using a cut-off grade of 10% magnetic iron. Additionally, there are 188 Mt of Inferred mineral resources grading 30.1% total iron and 18.4% magnetic iron.

Full mineral resource details and project economics can be found in the NI 43-101 compliant technical report entitled “Preliminary Economic Assessment of the Re-scoped Shymanivske Iron Ore Deposit” effective November 21, 2017, under the Company’s profile on SEDAR at?www.sedar.com.

Management

Black Iron’s management and board of directors is stacked with experts well-versed in successfully building and operating iron ore projects. CEO Matt Simpson, P.Eng. is the former general manager of Mining for Rio Tinto’s Iron Core Company of Canada and worked for Hatch designing global metallurgical refineries. He is also a Qualified Person as defined by NI 43-101. Chairman Bruce Humphrey is the former COO of GoldCorp and former chairman of Consolidated Thompson Iron Ore mines which was sold to Cliff’s resources for US$4.9 billion.

Les Kwasik, COO, has over 40 years of hands-on experience building and operating mines globally with companies such as INCO (VALE) and Xstrata (Glencore). Paul Bozoki, CFO, is the former CFO of CD Capital Partners, operating in the Ukraine. Bill Hart, senior vice president of corporate development, has over 30 years of experience selling iron ore while working for Rio Tinto, Cliffs Natural Resources and most recently Roy Hill Holdings Ltd. Ivan Markovich was recently engaged in the capacity of Black Iron’s vice president of Government and Community Relations to leverage his extensive network of relationships with senior Ukraine government officials.

Black Iron Inc. (BKIRF), closed the day's trading session at $0.0515, up 4.15%, on 26,500 volume with 6 trades. The average volume for the last 3 months is 45,831 and the stock's 52-week low/high is $0.0285/$0.0939.

Recent News

chart

Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Medical Cannabis Payment Solutions (OTC PINK: REFG), a leading provider of regulatory-compliant financial services for state-sanctioned marijuana, today announced that it has entered into an agreement with DeltaNevada, a Nevada investment and management company that has entered the CBD extraction and processing space, to provide its platform and services to process payments and to provide depository services.

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.02395, up 48.76%, on 3,413,301 volume with 131 trades. The average volume for the last 3 months is 556,285 and the stock's 52-week low/high is $0.008/$0.075.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Innovative hemp and cannabis corporation Marijuana Company of America (OTCQB: MCOA) today announced that its wholly owned subsidiary hempSMART(TM) has entered into a strategic marketing agreement with MassRoots, Inc. (OTCQB: MSRT). To view the full press release, visit: http://nnw.fm/zZ5jL.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0169, up 5.62%, on 15,514,794 volume with 637 trades. The average volume for the last 3 months is 12,007,570 and the stock's 52-week low/high is $0.01025/$0.0499.

Recent News

chart

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Emerging leader in the cannabis, hemp, and cannabidiol (“CBD”) marketplace Golden Developing Solutions (OTC: DVLP) this morning provided a shareholder update via a letter from its CEO. According to the update, the company has gained traction in the cannabis space as a service provider with its popular Where’s Weed app and portal, as well as expanded its market footprint to move into the CBD space with its Where’s CBD portal. To view the full press release, visit: http://nnw.fm/4AwlF.

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.015, up 0.67%, on 2,171,819 volume with 86 trades. The average volume for the last 3 months is 2,450,528 and the stock's 52-week low/high is $0.0122/$0.14.

Recent News

chart

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE).

Global Payout (OTC: GOHE) along with its wholly-owned subsidiary MTrac Tech Corporation today announced that Carol Gabel, a valued member of the company’s government relations team at MGR2, was invited to speak at the New Jersey Cannabis Insider event to be held on April 3, 2019. To view the full press release, visit: http://nnw.fm/Q7KfY.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today’s banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout’s management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and “high-risk” market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and “high-risk” enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions.

Global Payout, Inc. (GOHE), closed the day's trading session at $0.0054, up 0.09%, on 6,150,967 volume with 53 trades. The average volume for the last 3 months is 6,256,514 and the stock's 52-week low/high is $0.0041/$0.0315.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a food biosciences company, has developed a proprietary technology that has revolutionized the way cannabidiol (CBD) and other non-psychoactive cannabinoids are delivered into the bloodstream. NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://nnw.fm/LXRP.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.21, off by 3.20%, on 215,749 volume with 308 trades. The average volume for the last 3 months is 170,355 and the stock's 52-week low/high is $0.75/$2.43.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.